Call for Abstract
23rd European Heart Disease and Heart Failure Congress, will be organized around the theme “Mission to fight against Heart Diseases and Heart Failure”
Euro Heart Failure 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Euro Heart Failure 2018
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Heart Disease is a major cause of disability and premature death throughout the world. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, generally in middle age. Acute coronary events (heart attacks) and cerebrovascular events (strokes) frequently occur suddenly, and are often fatal before medical care can be given. Heart Conferences promotes awareness against Risk factor modification which reduces clinical events and premature death in people with established cardiovascular disease as well as in those who are at high cardiovascular risk due to one or more risk factors.
Cardiovascular Medicine Conferences are the most comprehensive provider of cardiovascular services specializing in the prevention, detection, management and treatment of adult cardiovascular diseases. Cardiovascular Medicine Conferences is a platform for postgraduate education and scientific work in the fields of cardiology, angiology, hypertension and cardiac and vascular surgery.
Innovative advancements and researches are being made in cardiac surgery every day. The world's all advanced technology and most experienced cardiovascular surgeons and cardiologists are welcome here. Cardiovascular surgeries are those which performed on the heart and circulatory system including the major veins and arteries. Cardiovascular procedures performed by cardiac surgeons.
Our Conference Euro Heart Failure 2018 invites worlds all cardiovascular surgeons, cardiologists and heart specialists to grace their presence in this global event and share their innovative ideas at this grand international scientific platform.
Heart failure, sometimes known as congestive heart failure, occurs when your heart muscle doesn't pump blood as well as it should. Certain conditions, such as narrowed arteries in your heart (coronary artery disease) or high blood pressure, gradually leave your heart too weak or stiff to fill and pump efficiently. Not all conditions that lead to heart failure can be reversed, but treatments can improve the signs and symptoms of heart failure and help you live longer. Lifestyle changes — such as exercising, reducing salt in your diet, managing stress and losing weight — can improve your quality of life.
One way to prevent heart failure is to control conditions that cause heart failure, such as coronary artery disease, high blood pressure, diabetes or obesity
An arrhythmia is a problem with the rate or rhythm of your heartbeat. It means that your heart beats too quickly, too slowly, or with an irregular pattern. When the heart beats faster than normal, it is called tachycardia. When the heart beats too slowly, it is called bradycardia. The most common type of arrhythmia is atrial fibrillation, which causes an irregular and fast heartbeat. Many factors can affect your heart's rhythm, such as having had a heart attack, smoking, congenital heart defects, and stress. Some substances or medicines may also cause arrhythmias.
Molecular cardiology is a new and fast-growing area of cardiovascular medicine that aims to apply molecular biology techniques for the mechanistic investigation, diagnosis, prevention and treatment of cardiovascular disease. As an emerging discipline, it has changed conceptual thinking of cardiovascular development, disease etiology and pathophysiology. Although molecular cardiology is still at a very early stage, it has opened a promising avenue for understanding and controlling cardiovascular disease. With the rapid development and application of molecular biology techniques, scientists and clinicians are closer to curing heart diseases that were thought to be incurable 20 years ago. There clearly is a need for a more thorough understanding of the molecular mechanisms of cardiovascular diseases to promote the advancement of stem cell therapy and gene therapy for heart diseases. The present paper briefly reviews the state-of-the-art techniques in the following areas of molecular cardiology: gene analysis in the diseased heart; transgenic techniques in cardiac research; gene transfer and gene therapy for cardiovascular disease; and stem cell therapy for cardiovascular disease.
High blood pressure, also called hypertension, is a serious medical condition. It happens when the force of the blood pumping through your arteries is too strong. When your heart beats, it pushes blood through your arteries to the rest of your body. When the blood pushes harder against the walls of your arteries, your blood pressure goes up. Your blood pressure may be different at different times of the day. It is usually higher when you first wake up, after you exercise, or when you are under stress. Having higher blood pressure for short amounts of time is normal. However, when your blood pressure stays high for most of the time, it can cause serious health problems.
Cardiovascular nursing is a specialty that works with patients who suffer from numerous conditions of the cardiovascular system. Cardiovascular nurses facilitate treat conditions like unstable angina, myocardial infarction, cardiomyopathy, coronary artery disease, cardiac dysrhythmia and congestive heart failure under the direction of a heart specialist (cardiologist). Cardiovascular nurses perform postoperative care on a stress test evaluations, cardiac monitoring, surgical unit, health assessments and vascular monitoring. Cardiovascular nurses must have Advanced Cardiac Life Support and Basic Life Support certification. Cardiovascular nurses must possess specialized skills including defibrillation, electrocardiogram monitoring and medication administration by continuous intravenous drip. Cardiovascular nurses care for people with cardiovascular disease and interact with their patients families. They may monitor and treat acutely ill patients, or they may focus on cardiovascular rehabilitation helping patients make lifestyle changes to prevent the worsening of their disease.
In childhood a disorder which involves both the heart and lungs problems, called Paediatric Cardiopulmonary disease. Epicardial adipose tissue (EAT) is the visceral fat deposit around the heart and is commonly increased in obese subjects. EAT is related to Cardio Metabolic risk factors and non-alcoholic fatty liver disease (NAFLD) in adults, but this relationship is not well known in children. (MI) Myocardial infarction is rare in childhood and adolescence. Children usually have either an acute inflammatory condition of the coronary arteries diseases or an anomalous origin of the left coronary artery (LCA). Peripheral vascular diseases (PVDs) are circulation disorders that affect blood vessels outside of the heart and brain. In PVD, blood vessels are narrowed. Narrowing is usually caused by arteriosclerosis. We will be discussed more about the common problem of the baby heart as Cardiomyopathy, Myocarditis, Hypoplastic Left Heart Syndrome, Hypertension, Heart Murmur, Cardiac Arrest, Arrhythmogenic Right Ventricular Dysplasia, Cyanotic Heart Disease, and Paediatric Arrhythmia as well as more about Paediatric lungs disorders as Upper Airway Abnormalities, Child Interstitial Lung Disease (child), Chronic and Recurrent Respiratory Infections, Congenital Abnormalities and Paediatrics Chronic Obstructive Lung Diseases etc.
New tests are constantly being developed to further the understanding of disease, injury, and congenital (present at birth) or acquired abnormalities of the heart. The diagnostic tests in cardiology are methods of identifying heart conditions associated with healthy vs. unhealthy, pathologic heart function.
The scientific goal of this track is to understand the underlying causes and pathophysiology of obesity, diabetes, and associated metabolic diseases, as well as pursuing effective and safe interventions and therapeutics. Investigators in this division also have a special emphasis on women's health and on the developmental programming of metabolic diseases. This includes expertise in the central nervous system that controls appetite and energy expenditure, pancreas function, and adipose tissue function. Our investigators utilize a broad array of research tools including noninvasive imaging, complex whole animal studies on physiology and behavior, and in vitro and ex vivo techniques.
Even though we are a small division at this time, currently consisting of 5 core scientists and 4 staff scientists, we have over $7 million (direct costs) of funding active during 2012-2013, with 70% coming from NIH and the rest from industry collaborations. Furthermore, our external collaborators have almost $2.5 million in support during that time directly related to research using our Obese NHP Resource.
Heart disease is the leading cause of death in the western world. Each year in the U.S.A, more than 500,000 men and women die from coronary artery disease. During the past two decades, major strides have been made in the diagnosis and treatment of heart disease. Nuclear Cardiology has played a pivotal role in establishing the diagnosis of heart disease and in the assessment of disease extent and the prediction of outcomes in the setting of coronary artery disease. Nuclear cardiology studies use noninvasive techniques to assess myocardial blood flow, evaluate the pumping function of the heart as well as visualize the size and location of a heart attack. Among the techniques of nuclear cardiology, myocardial perfusion imaging is the most widely used.
A computed tomography scan — commonly called a CT scan or CAT scan — is a test that uses X-rays to view specific areas of your body. These scans use safe amounts of radiation to create detailed images of the body, which can help the doctor to detect any problems. A heart, or cardiac, CT scan is used to view your heart and blood vessels. A heart CT scan may also be called a coronary CT angiogram if it’s meant to view the arteries that bring blood to your heart. The test may be called a coronary calcium scan if it’s meant to determine whether there is a buildup of calcium in your heart.
The growth of cardiac applications of imaging techniques not traditionally handled by cardiologists such as cardiovascular magnetic resonance (CMR) and multidetector computed tomography (MSCT) requires great attention. Traditionally, cardiologists have been able to integrate all the diagnostic techniques into the cardiovascular department in order to facilitate an integrated delivery of care. To an extent this has happened also for nuclear cardiology, a field where cooperation with other nuclear medicine specialists is commonplace, but the presence of cardiology specialists during the stress examination and for the overall interpretation of results is generally accepted.
Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing (stenosis) of the coronary arteries of the heart found in coronary artery disease. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualise the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open. Various other procedures can also be performed. When coronary artery disease causes chest pain or a heart attack, percutaneous coronary interventions, such as angioplasty alone or with a stent, can restore blood flow to your heart.
Implantable devices have been used for decades to treat heart disease. The first pacemaker was implanted over 40 years ago, and implantable defibrillators were first used in the early 1980s. But the last few years have witnessed a surge in both the types of devices being tested for heart-failure treatment, and in the optimism of experts about their usefulness.
An implantable cardioverter defibrillator (ICD) is a microcomputer that is implanted under the skin of your upper chest area. It is small enough to fit in the palm of your hand. It monitors your heart rate and delivers therapy in the form of small electrical pulses. A cardiac resynchronization therapy implantable cardioverter defibrillator (CRT-D) is a type of specialized ICD used to treat heart failure. Getting a cardiac resynchronization therapy (CRT) heart device is not an open-heart procedure. Before surgery, medication is usually given to make you sleepy and comfortable. The procedure is performed under local anesthesia.
Cardiovascular Toxicology deals with the adverse effects on the heart or blood systems which result from exposure to toxic chemicals. It describes safety data of detrimental effects of new cardiovascular drugs. Pharmacology of vascular endothelium deals with alterations of endothelial cells and the vasculature play a central role in the pathogenesis of a broad spectrum of the most dreadful of human diseases, as endothelial cells have the key function of participating in the maintenance of patent and functional capillaries.
Our all Cardiology conferences has Case Studies act as informative examples to people who might also faces similar problems. Generally, Case Studies in Cardiovascular Medicine, should detail a particular medical case, reporting the background of the patient. They should discuss investigations undertaken in order to determine a diagnosis or differentiate between possible diagnoses, and should indicate the type of treatment the patient underwent as a result. In one piece we can conclude that Case Studies is an useful and informative part of every doctor or physician's medical education, which actually encourage us to include this session track on our international heart failure conference which is going to be held at Paris, France.